0
Comments
60
Views
The Nucleotide Sugar Synthesis Services Market is expanding as pharmaceutical and biotechnology companies increasingly require customized nucleotide sugars for drug development, glycosylation research, diagnostics, and bioprocessing. According to WiseGuyReports, the market was valued at approximately USD 800 million in 2025 and is projected to reach USD 1.5 billion by 2035, registering a CAGR of 5.9% during the forecast period.
Nucleotide sugars are important biochemical intermediates involved in glycosylation and carbohydrate metabolism. Growing investment in biopharmaceutical development, personalized medicine, and synthetic biology is creating additional demand for specialized synthesis services.